Projects

scientist
Mgr. Veronika Farkašová, PhD

International

Finished
  • Realising the therapeutic potential of novel cardioprotective therapies
    Program: COST
    Duration: 19. 10. 2017 – 18. 4. 2022
  • Effect of pathological states on cardiac resistance against myocardial ischemia: study of molecular mechanisms and novel approaches to cardioprotection
    Program: Inter-academic agreement
    Duration: 1. 1. 2015 – 31. 12. 2017
  • Study of clinically applicable novel forms of preconditioning as an alternative method of cardiac protection against acute ischemia in the organism challenged with civilization diseases
    Program: Inter-governmental agreement
    Duration: 1. 1. 2015 – 31. 12. 2015
  • Intracellular signaling pathways and nuclear transcription factor activation in cardiac adaptation to ischemia/reperfusion injury
    Program: Bilateral - other
    Duration: 1. 1. 2011 – 31. 12. 2015
  • The effect of lifestyle-related risk factors on the intrinsic defensive mechanisms in the myocardium
    Program: Inter-governmental agreement
    Duration: 1. 1. 2012 – 31. 12. 2013

National

Current
  • Targeted suppression of pro-inflammatory and pro-fibrotic signaling pathways to prevent heart failure and occurrence of malignant arrhythmias
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2026
  • New aspects of cardioprotection by natural antioxidants: role of ageing and lifestyle-related comorbidities
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2026
  • Study of the role of innate cardioprotection in the rat myocardium evoked by non-pharmacological adaptive stimuli under normal and pathological conditions.
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
  • Necroptotic and pleiotropic effects of RIP3 kinase acting as a convergent point in cardiac cell loss: understanding the basic mechanisms in the ischemic heart with or without metabolic stress as a tool for designing therapeutic approaches.
    Program: SRDA
    Duration: 1. 7. 2021 – 30. 6. 2025
  • Cardioprotective potential of TRP channels: the role in remodelation, inflammation and calcium dysregulation
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
Finished
  • Crosslinking of some necrosis-like forms of cell death: signaling and a multi-targeting tool to mitigate heart damage due to ischemia?
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • Research of magnetic forms of iron in development of cardiovascular diseases and behavioural disorders
    Program: SRDA
    Duration: 1. 7. 2017 – 30. 6. 2021
  • Dynamics of myocardial damage: a role of necroptotic cell death and survival of cardiomyocytes.
    Program: SRDA
    Duration: 1. 7. 2016 – 30. 6. 2020
  • Hypoxia in the prevention of heart failure in rats and its influence in various stages of heart failure: Characteristics of functional, structural and molecular changes.
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2019
  • -
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2019
  • Study of the clinically relevant forms of preconditioning as an alternative method of myocardial protection against acute ischemia in the organism challenged with civilization diseases
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2017
  • The effect of the lifestyle-related risk factors on the adaptive processes in the ischemic myocardium
    Program: SRDA
    Duration: 1. 7. 2012 – 31. 12. 2015
  • Centre of excellence of SAS for research of regulatory role of nitric oxide in civilization diseases
    Program:
    Duration: 1. 8. 2011 – 30. 6. 2015
  • Sex differences in etiopathogenesis of social stress-related cardiovascular and behavioral disorders in individuals with predisposition to hypertension.
    Program: SRDA
    Duration: 1. 5. 2011 – 31. 10. 2014
  • The effect of aliskerin loaded nanoparticles in experimental hypertension
    Program: SRDA
    Duration: 1. 5. 2011 – 31. 10. 2014
Employees